NathanVanderVeenMD

PubMed

• 4 citations
  Combination Therapy With Bortezomib in Renal Medullary Carcinoma: A Case Series
  Karine Tawagi, Nathan VanderVeen, Marc R. Matrana, Robert Vasquez> ;Clinical Genitourinary Cancer. 2021 Aug 27
• 2 citations
  Very Late Relapse in Pediatric Acute Myeloid Leukemia: A Case Report and Brief Literature Review.
  Nathan VanderVeen, Matthew Fletcher, Robert Vasquez, Graham D Unis> ;Journal of Pediatric Hematology/oncology. 2021 Aug 1
• 7 citations
  Encephalitis with coinfection by Jamestown canyon virus (JCV) and varicella zoster virus (VZV).
  Nathan VanderVeen, Nikki Nguyen, Kenny Hoang, Jason Parviz, Tahuriah Khan, Andrew Zhen, Brett W. Jagger> ;Idcases. 2020 Oct 8
• 1 citations
  Is thrombocytopenia progressing? Immune thrombocytopenic purpura as warning sign for significant blood disease
  Nathan VanderVeen, Karan Gupta, Robert Vasquez, Rajasekharan Warrier> ;Clinical Pediatrics. 2020 May 1
• 7 citations
  Perceived Barriers and Trends in HPV Vaccination via Patient Survey Responses at Kalamazoo, Michigan's Federally-Qualified Health Center.
  Nathan VanderVeen, Arika Wieneke, Samantha Tran, Amie Kim, Kathryn Davis, Debra Taubel> ;Journal of Community Health. 2020 Feb 1
• 1 citations
  Improving Inferior Vena Cava Filter Retrieval and Success Rates Using an Office Endovascular Center.
  Nathan VanderVeen, Jeffrey Friedman, Mark Rummel, Daniel Johnston, John S. Munn, Krishna M. Jain> ;Annals of Vascular Surgery. 2020 Jan 13
• 6 citations
  Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral ...
  Nathan VanderVeen, Nicholas Raja, Elizabeth Yi, Henry D. Appelman, Philip Ng, Donna Palmer, Daniel Zamler, Marta Dzaman, Pedro R. Lowenstein, Maria G. Castro> ;Human Gene Therapy Methods. 2016 Apr 6
• 26 citations
  Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy.
  Hikmat Assi, Christopher Paran, Nathan VanderVeen, Jonathan C. Savakus, Robert Doherty, Emanuele Petruzzella, James D. Hoeschele, Henry D. Appelman, Leda Raptis, Tom M...> ;The Journal of Pharmacology and Experimental Therapeutics. 2014 Jun 1
• 8 citations
  Marmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectors.
  Nathan VanderVeen, Christopher Paran, Ashley Appelhans, Johnny Krasinkiewicz, Rosemary M. Lemons, Henry D. Appelman, Robert Doherty, Donna Palmer, Philip Ng, Pedro R. ...> ;Molecular Therapy. Methods & Clinical Development. 2014 Jan 1
• 9 citations
  Effectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a phase I clinical trial for glioma.
  Nathan VanderVeen, Christopher Paran, Jonathan Krasinkiewicz, Lili Zhao, Donna Palmer, Shawn L. Hervey-Jumper, Philip Ng, Pedro R. Lowenstein, Maria G. Castro> ;Human Gene Therapy. Clinical Development. 2013 Aug 15
• 20 citations
  Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a pr...
  Mariana Puntel, Ghulam Muhammad A.K.M., Catherine Farrokhi, Nathan VanderVeen, Christopher Paran, Ashley Appelhans, Kurt M. Kroeger, Alireza Salem, Liliana M. Lacayo, ...> ;Toxicology and Applied Pharmacology. 2013 May 1
• Join now to see all